FDA Makes Alzheimer’s Drug Leqembi Widely Accessiblenews2023-07-06T21:26:16+00:00July 6th, 2023|The New York Times|
How the Shortage of a $15 Cancer Drug Is Upending Treatmentnews2023-06-26T15:47:37+00:00June 26th, 2023|The New York Times|
La FDA aprueba Eroxon, un gel contra la disfunción eréctilnews2023-06-23T23:29:32+00:00June 23rd, 2023|The New York Times|
Erectile Dysfunction Treatment: What to Know About Eroxon, a New Topical Gelnews2023-06-21T16:30:47+00:00June 21st, 2023|The New York Times|
FDA Panel Recommends RSV Shot to Protect Infantsnews2023-06-08T20:11:09+00:00June 8th, 2023|The New York Times|
FDA Approves Pfizer’s RSV Vaccine for Adults 60 and Oldernews2023-05-31T22:35:58+00:00May 31st, 2023|The New York Times|
Why The F.D.A. Should Move Birth Control Over the Counternews2023-05-22T14:28:45+00:00May 22nd, 2023|The New York Times|
Drug Shortages Near an All-Time High, Leading to Rationingnews2023-05-17T13:31:02+00:00May 17th, 2023|The New York Times|
Esto se sabe sobre Opill, la nueva ‘minipíldora’ anticonceptivanews2023-05-13T09:00:31+00:00May 13th, 2023|The New York Times|
FDA Approves New Drug to Treat Hot Flashesnews2023-05-12T20:09:58+00:00May 12th, 2023|The New York Times|
